Search details
1.
Real-World Clinical Performance of a DNA-Based Comprehensive Genomic Profiling Assay for Detecting Targetable Fusions in Nonsquamous NSCLC.
Oncologist
; 2024 Feb 24.
Article
in English
| MEDLINE | ID: mdl-38401173
2.
Mismatch repair deficiency, next-generation sequencing-based microsatellite instability, and tumor mutational burden as predictive biomarkers for immune checkpoint inhibitor effectiveness in frontline treatment of advanced stage endometrial cancer.
Int J Gynecol Cancer
; 33(4): 504-513, 2023 04 03.
Article
in English
| MEDLINE | ID: mdl-36750267
3.
Embracing an integromic approach to tissue biomarker research in cancer: Perspectives and lessons learned.
Brief Bioinform
; 18(4): 634-646, 2017 07 01.
Article
in English
| MEDLINE | ID: mdl-27255914
4.
Association of Patient Characteristics and Tumor Genomics With Clinical Outcomes Among Patients With Non-Small Cell Lung Cancer Using a Clinicogenomic Database.
JAMA
; 321(14): 1391-1399, 2019 04 09.
Article
in English
| MEDLINE | ID: mdl-30964529
5.
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer.
Lab Invest
; 98(1): 15-26, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29251737
6.
Molecular fixative enables expression microarray analysis of microdissected clinical cervical specimens.
Exp Mol Pathol
; 96(2): 168-77, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-24412268
7.
PD-L1 Status and Survival in Patients With Lung Cancer-Reply.
JAMA
; 322(8): 783-784, 2019 08 27.
Article
in English
| MEDLINE | ID: mdl-31454037
8.
Clinical and Genomic Factors Associated with Greater Tumor Mutational Burden in Prostate Cancer.
Eur Urol Open Sci
; 55: 45-49, 2023 Sep.
Article
in English
| MEDLINE | ID: mdl-37662703
9.
Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis.
J Immunother Cancer
; 11(1)2023 01.
Article
in English
| MEDLINE | ID: mdl-36650021
10.
Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden.
JAMA Netw Open
; 6(1): e2252244, 2023 01 03.
Article
in English
| MEDLINE | ID: mdl-36689222
11.
Quantifying the Value of Multigene Testing in Resected Early Stage Lung Adenocarcinoma.
J Thorac Oncol
; 18(4): 476-486, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36494074
12.
Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness.
JCO Precis Oncol
; 7: e2300092, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37410975
13.
Genomic Profiles and Clinical Outcomes of Penile Squamous Cell Carcinoma With Elevated Tumor Mutational Burden.
JAMA Netw Open
; 6(12): e2348002, 2023 Dec 01.
Article
in English
| MEDLINE | ID: mdl-38150257
14.
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer.
Clin Cancer Res
; 28(22): 4917-4925, 2022 11 14.
Article
in English
| MEDLINE | ID: mdl-36088616
15.
Complementary Roles for Tissue- and Blood-Based Comprehensive Genomic Profiling for Detection of Actionable Driver Alterations in Advanced NSCLC.
JTO Clin Res Rep
; 3(9): 100386, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-36089920
16.
Genomic Biomarkers and Genome-Wide Loss-of-Heterozygosity Scores in Metastatic Prostate Cancer Following Progression on Androgen-Targeting Therapies.
JCO Precis Oncol
; 6: e2200195, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35820087
17.
Pan-cancer analysis of CD274 (PD-L1) mutations in 314,631 patient samples and subset correlation with PD-L1 protein expression.
J Immunother Cancer
; 9(6)2021 06.
Article
in English
| MEDLINE | ID: mdl-34130989
18.
Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response.
Cancer Discov
; 11(2): 282-292, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33127846
19.
Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors.
JAMA Netw Open
; 3(10): e2025109, 2020 10 01.
Article
in English
| MEDLINE | ID: mdl-33119110
20.
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.
Chest
; 158(4): 1723-1733, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32464188